Clinical significance of serum expression of GROβ in esophageal squamous cell carcinoma

被引:17
作者
Dong, Qiao-Mei [1 ,2 ]
Zhang, Jin-Qiang [1 ,2 ]
Li, Qian [1 ,2 ]
Bracher, Jacqueline C. [4 ]
Hendricks, Denver T. [4 ]
Zhao, Xiao-Hang [1 ,2 ,3 ]
机构
[1] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100021, Peoples R China
[2] Peking Union Med Coll, Beijing 100021, Peoples R China
[3] Navy Gen Hosp, Ctr Basic Med Sci, Beijing 100048, Peoples R China
[4] Univ Cape Town, Fac Hlth Sci, Div Med Biochem, ZA-7925 Cape Town, South Africa
基金
中国国家自然科学基金;
关键词
GRO beta; Esophageal squamous cell carcinoma; Metastasis; Cytokine; Tumor markers; CXC CHEMOKINES; CANCER CELLS; METASTASIS; PROLIFERATION; NEURONS; RISK;
D O I
10.3748/wjg.v17.i21.2658
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To determine the association between serum levels of growth-related gene product beta (GRO beta) and clinical parameters in esophageal squamous cell carcinoma (ESCC). METHODS: Using enzyme-linked immunosorbent assay, serum GRO beta levels were measured in ESCC patients (n = 72) and healthy volunteers (n = 83). The association between serum levels of GRO beta and clinical parameters of ESCC was analyzed statistically. RESULTS: The serum GRO beta levels were much higher in ESCC patients than in healthy controls (median: 645 ng/L vs 269 ng/L, P < 0.05). Serum GRO beta levels were correlated positively with tumor size, lymph node metastasis, and tumor-node-metastasis (TNM) staging, but not with gender or the histological grade of tumors in ESCC patients. The sensitivity and specificity of the assay for serum GRO beta were 73.61% and 56.63%, respectively. CONCLUSION: GRO beta may function as an oncogene product and contribute to tumorigenesis and metastasis of ESCC. (C) 2011 Baishideng. All rights reserved.
引用
收藏
页码:2658 / 2662
页数:5
相关论文
共 38 条
[1]  
Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1
[2]  
Bruyere C, 2010, CANCER
[3]   Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation [J].
Charo, IF ;
Ransohoff, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :610-621
[4]   CXC chemokines play a critical role in liver injury, recovery, and regeneration [J].
Clarke, Callisia N. ;
Kuboki, Satoshi ;
Tevar, Amit ;
Lentsch, Alex B. ;
Edwards, Michael .
AMERICAN JOURNAL OF SURGERY, 2009, 198 (03) :415-419
[5]   Chemokines - Chemokines and cell migration in secondary lymphoid organs [J].
Cyster, JG .
SCIENCE, 1999, 286 (5447) :2098-2102
[6]   Lymphotoxin-β receptor activation by lymphotoxin-α1β2 and LIGHT promotes tumor growth in an NFκB-dependent manner [J].
Daller, Barbara ;
Muesch, Werner ;
Roehrl, Johann ;
Tumanov, Alexei V. ;
Nedospasov, Sergei A. ;
Maennel, Daniela N. ;
Schneider-Brachert, Wulf ;
Hehlgans, Thomas .
INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (06) :1363-1370
[7]   CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer [J].
Deng, Ling ;
Chen, Nianyong ;
Li, Yan ;
Zheng, Hong ;
Lei, Qianqian .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2010, 1806 (01) :42-49
[8]   Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer [J].
Derwinger, Kristoffer ;
Kodeda, Karl ;
Bexe-Lindskog, Elinor ;
Taflin, Helena .
ACTA ONCOLOGICA, 2010, 49 (01) :57-62
[9]   Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival [J].
Doll, Dietrich ;
Keller, Larissa ;
Maak, Matthias ;
Boulesteix, Anne-Laure ;
Siewert, Joerg R. ;
Holzmann, Bernhard ;
Janssen, Klaus-Peter .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (05) :573-581
[10]   GROβ and its downstream effector EGR1 regulate cisplatin-induced apoptosis in WHCO1 cells [J].
Dong, Qiaomei ;
Zhang, Jinqiang ;
Hendricks, Denver T. ;
Zhao, Xiaohang .
ONCOLOGY REPORTS, 2011, 25 (04) :1031-1037